Editing
Synthesis of oleylamine
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==== Lab scale purification<br> ==== To a 250 cm3 round-bottomed flask fitted with magnetic stirrer, nitrogen inlet, temperature probe, condenser and a 100 cm3 pressure-equalized dropping funnel, was charged crude elaidylamine (17.0 g, 63.6 mmol) and '''t-butyl methyl ether''' (85 cm3, 5 volumes). The substrate did not dissolve, so an additional 85 cm3 of TBME was added. Although a solution was not obtained, the resultant slurry was deemed adequate for further processing. The stirred slurry was treated with 37% '''hydrochloric acid''' (7.6 g, 1.2 eq.). During this addition the slurry became very thick and difficult to stir, suggesting that '''elaidylamine hydrochloride is poorly soluble in TBME'''. '''Water (100 cm3) was therefore added''' which eventually yielded a clear monophasic solution. The hydrochloride was then precipitated by addition to excess '''acetonitrile''' (750 cm3). The resultant suspension was cooled to 0-5°C, stirred for 30 minutes, filtered and washed with cold acetonitrile (2 x 200 cm3). The solid was then dried under vacuum at 30-35°C to yield elaidylamine hydrochloride as a white crystalline powder (12.1 g, 63%) The hydrochloride (12.1 g) was then slurried in TBME (180 cm3, 15 volumes) and treated with 2M sodium hydroxide solution (40 cm3, 2 eq.). During the addition the solid dissolved to give a bi-phasic solution which was stirred overnight. The mixture was then transferred to a separating funnel, the'''lower aqueous layer removed,''' and the organic phase washed with water (2 x 50 cm3). The resultant product solution was then evaporated to yield elaidylamine as clear oil, which solidified upon cooling to room temperature (10.7 g, 100% from hydrochloride, 63% from crude amine).<br> <br> [[Category:Transfection]] [[Category:Paul]]
Summary:
Please note that all contributions to ELN may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
ELN:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
View history
More
Search
Navigation
Category:
Main page
To Do
Tasks
My ELN
Weekly Reports
Buffer Recipe
SOP
Protocols
Inventories
Projects
Products
Customers
Contacts
Suppliers
Vectors
Vector Map
Clones
Cloning
Sequencing
NGS
Protein Expression
Purchaseing
QC
293 Expression
CHO Expression
Sf9 Expression
Protein Purification
Stem Cells
Cytokines
Protein Kinases
GPCR
Cell Lines
Competent Cells
Viral Proteins
VLP
Baculovirus
AAV
Adenovirus
Lentivirus
Virus Titering
Antibodies
Transfection
ELISA
qPCR RT-PCR
ImmunoAssay
Multiplex BioAssa
Lateral_Flow
Conjugation
Compounds Synthesis
BioEngineering
GenomeEngineering
Services
Software
Ideas
Links
Knowledgebase
Employees
Company
Tools
What links here
Related changes
Page information
Navigation
Special pages